MITIGATE-NeoBOMB1, a Phase I/IIa Study to Evaluate Safety, Pharmacokinetics and Preliminary Imaging of 68Ga-NeoBOMB1, a Gastrin-releasing Peptide Receptor Antagonist, in GIST Patients.

Autor: Gruber, Leonhard, Jimenez, Luis David, Decristoforo, Clemens, Uprimny, Christian, Glatting, Gerhard, Hohenberger, Peter, Schoenberg, Stefan O., Reindl, Wolfgang, Orlandi, Francesca, Mariani, Maurizio, Jaschke, Werner, Virgolini, Irene
Zdroj: Journal of Nuclear Medicine; Dec2020, Vol. 61 Issue 12, p1-40, 40p
Databáze: Complementary Index